Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan

[1]  D. Low,et al.  Prevalence and Mechanisms of Macrolide Resistance in Invasive and Noninvasive Group B Streptococcus Isolates from Ontario, Canada , 2001, Antimicrobial Agents and Chemotherapy.

[2]  K. Matsubara,et al.  Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. , 2001, The Journal of antimicrobial chemotherapy.

[3]  Y. Jordán,et al.  Infección recidivante por Streptococcus agalactiae , 1998 .

[4]  A. Nakamura.  [Prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in a children's hospital]. , 1997, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[5]  S. Kuroki,et al.  [Studies on efficacy and safety of panipenem/betamipron against infections in pediatrics and on its movement to cerebrospinal fluid including cases of penicillin-resistant Streptococcus pneumoniae meningitis]. , 1992, The Japanese journal of antibiotics.

[6]  H. Sakata,et al.  Antibiotic Susceptibility of Type b Haemophilus influenzae and Streptococcus pneumoniae, and Antibiotic Concentration in Cerebrospinal Fluid , 1990, Acta paediatrica Japonica : Overseas edition.

[7]  J. Selkon,et al.  The penetration of antibiotics into cerebrospinal fluid and brain tissue. , 1978, The Journal of antimicrobial chemotherapy.

[8]  P. Gardner.  Antimicrobial drug therapy in pediatric practice. , 1974, Pediatric clinics of North America.

[9]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[10]  W. Traub,et al.  Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. , 1997, Chemotherapy.

[11]  春田恒和.  Panipenem/Betamipron の小児科領域感染症に対する有効性, 安全性の検討および髄液移行の検討. ペニシリン耐性肺炎球菌髄膜炎症例を含めて , 1992 .